Clinical Trial Update: Using CTA Measures to Define Cardiac Risk In NFL Alumni

View source ↗

Summary

A clinical trial update indicates a CTA-based study to define cardiac risk in NFL alumni is currently recruiting, sponsored by HeartFlow, Inc.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Coronary Artery Disease
• Coronary Atherosclerosis
• Heart Disease

Snippet

Sponsor: HeartFlow, Inc. | Conditions: Coronary Artery Disease (CAD), Heart Disease | Status: RECRUITING